XML 12 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Operations (unaudited) (USD $)
In Thousands, except Per Share data
 3 Months Ended 6 Months Ended
Jul. 03, 2011
Jun. 27, 2010
Jul. 03, 2011
Jun. 27, 2010
Condensed Consolidated Statements of Operations [Abstract]        
Revenues $ 43,555 $ 33,647 $ 72,011 $ 70,116
Cost of products sold 31,758 24,641 55,676 51,271
Gross margin 11,797 9,006 16,335 18,845
Operating expenses:        
Research and development (including $79, $95, $157 and $219, respectively, of amortization of intangible assets) 2,114 1,883 4,621 3,590
Selling, general, and administrative (including $78, $80, $157 and $247, respectively, of amortization of intangible assets) 6,820 6,137 12,971 12,481
Total operating expenses 8,934 8,020 17,592 16,071
Operating income (loss) 2,863 986 (1,257) 2,774
Other income (expense):        
Interest income 1   2  
Interest expense (162) (215) (318) (710)
Miscellaneous (9) (124) 290 (83)
Income (loss) from continuing operations before income taxes 2,693 647 (1,283) 1,981
Income tax provision-current 63 28 67 66
Income tax provision-deferred 67 39 133 94
Total income taxes 130 67 200 160
Net income (loss) from continuing operations 2,563 580 (1,483) 1,821
Discontinued operations:        
Loss from discontinued operations, net of tax (2,139) (563) (3,796) (1,508)
Net income (loss) 424 17 (5,279) 313
Net (income) loss attributable to noncontrolling interest 15 3 28 (6)
Net income (loss) attributable to Ultralife $ 439 $ 20 $ (5,251) $ 307
Net income (loss) attributable to Ultralife common shareholders - basic        
Continuing operations $ 0.15 $ 0.03 $ (0.08) $ 0.11
Discontinued operations $ (0.12) $ (0.03) $ (0.22) $ (0.09)
Total $ 0.03 $ 0 $ (0.30) $ 0.02
Net income (loss) attributable to Ultralife common shareholders - diluted        
Continuing operations $ 0.15 $ 0.03 $ (0.08) $ 0.11
Discontinued operations $ (0.12) $ (0.03) $ (0.22) $ (0.09)
Total $ 0.03 $ 0 $ (0.30) $ 0.02
Weighted average shares outstanding - basic 17,296 17,164 17,286 17,089
Weighted average shares outstanding - diluted 17,308 17,169 17,286 17,094